Nutritional Compounds: Can They Have An Impact With Diabetic Neuropathy?
- Volume 21 - Issue 3 - March 2008
- 6154 reads
- 0 comments
Drs. David, Decker and Rozelle are Fellows of the American College of Foot and Ankle Surgeons. Drs. Hulst and Meyer are Diplomates of the American Board of Podiatric Surgery. Drs. David, Hulst, Decker, Meyer, Rozelle and Bergsma are in practice at the Foot and Ankle Center of West Michigan. Dr. Gostine is a pain management physician and the President of Michigan Pain Consultants. Dr. Pawl is an oncologist in Grand Rapids, Michigan. Dr. Steinberg is an Assistant Professor in the Department of Plastic Surgery at the Georgetown University School of Medicine in Washington, D.C. Dr. Steinberg is a Fellow of the American College of Foot and Ankle Surgeons.
Editor’s note: For related articles, see “A Guide To Nutritional Supplements For Patients With Diabetes” in the March 2006 issue or “Current And Emerging Options In Treating Diabetic Neuropathy” in the March 2005 issue. For other related articles, visit the archives at www.podiatrytoday.com.
1. Nickander KK, Schmelzer JD, Rohwer DA, Low PA. Effect of alpha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J Neurol Sci. 1994 Oct; 126(1):6-14.
2. Marenzi G, Assanelli E, Marana I, et al. N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty. N Engl J Med 2006;354:2773-2782.
3. Yu JX, Zhang YD, Yin XX, et. al. Protective effects of bendazac lysine on diabetic peripheral neuropathy in streptozotocin-induced diabetic rats. Clin Exp Pharmacol Physiol. 2006 Dec;33(12):1231-8.
4. Ford I, et al. The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism. 2001 Aug;50(8):868-75.
5. Nakamura J, Koh N, Sakakibara F, et al. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. J Pharmacol Exp Ther. 1998 Dec;287(3):897-902.
6. Karihaloo AK, Joshi K, Chopra JS. Effect of sorbinil and ascorbic acid on myo-inositol transport in cultured rat Schwann cells exposed to elevated extracellular glucose. J Neurochem. 1997 Nov;69(5):2011-8.
7. Meister A. Glutathione, ascorbate and cellular protection. Cancer Res 1994;54:1969S-1975S.
8. Kidd PM. Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1997;1:155-176.
9. Weber GF. Final common pathways in neurodegenerative diseases: regulatory role of the glutathione cycle. Neurosci Biobehav Rev 1999;23:1079-1086.
10. Vijayalingam S, Parthiban A, Shanmugasundaram KR, et al. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diab Med 1996;13:715-719.